- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
889
Companies which are more than 50% undervalued based on analyst price target.
889 companies
Novo Nordisk
Market Cap: DKK 1.9t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 421.25
7D
0.2%
1Y
-51.4%
Regeneron Pharmaceuticals
Market Cap: US$60.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$563.16
7D
1.6%
1Y
-37.2%
Daiichi Sankyo Company
Market Cap: JP¥6.0t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,214.00
7D
3.5%
1Y
-30.7%
UCB
Market Cap: €25.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€136.30
7D
2.1%
1Y
12.5%
IQVIA Holdings
Market Cap: US$25.4b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$143.91
7D
-1.1%
1Y
-36.9%
WuXi AppTec
Market Cap: CN¥151.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥52.85
7D
1.4%
1Y
25.2%
Biogen
Market Cap: US$17.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$118.61
7D
3.0%
1Y
-39.0%
Teva Pharmaceutical Industries
Market Cap: US$15.6b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$13.65
7D
1.4%
1Y
6.1%
Genmab
Market Cap: DKK 81.9b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,291.50
7D
5.4%
1Y
-35.6%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.17
7D
4.1%
1Y
-33.2%
Illumina
Market Cap: US$11.3b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$71.20
7D
-4.8%
1Y
-39.4%
ICON
Market Cap: US$11.3b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$139.32
7D
-3.3%
1Y
-51.7%
Neurocrine Biosciences
Market Cap: US$10.1b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$101.38
7D
11.6%
1Y
-23.2%
Moderna
Market Cap: US$9.6b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$24.72
7D
-5.7%
1Y
-75.6%
Viatris
Market Cap: US$9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$7.56
7D
0.3%
1Y
-32.8%
Exact Sciences
Market Cap: US$7.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$41.58
7D
-6.5%
1Y
-31.8%
Bio-Techne
Market Cap: US$7.6b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$48.10
7D
-5.2%
1Y
-22.6%
Chongqing Zhifei Biological Products
Market Cap: CN¥53.4b
Chongqing Zhifei Biological Products Co., Ltd.
300122
CN¥22.29
7D
-3.1%
1Y
-44.9%
Roivant Sciences
Market Cap: US$7.2b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.
ROIV
US$10.15
7D
2.9%
1Y
-3.0%
Tempus AI
Market Cap: US$7.0b
Operates as a healthcare technology company.
TEM
US$40.45
7D
-4.0%
1Y
n/a
Revolution Medicines
Market Cap: US$6.8b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$36.76
7D
2.9%
1Y
5.3%
Corcept Therapeutics
Market Cap: US$6.6b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$62.24
7D
-9.3%
1Y
171.2%
BridgeBio Pharma
Market Cap: US$6.4b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$33.87
7D
-0.1%
1Y
36.9%
Jazz Pharmaceuticals
Market Cap: US$6.2b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$102.78
7D
2.3%
1Y
-6.5%
Legend Biotech
Market Cap: US$6.0b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$32.80
7D
2.5%
1Y
-29.0%
Grifols
Market Cap: €5.0b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF
€8.07
7D
3.0%
1Y
-3.3%
Financière de Tubize
Market Cap: €4.9b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€110.20
7D
1.8%
1Y
19.9%
Bruker
Market Cap: US$5.5b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$36.28
7D
-6.4%
1Y
-53.3%
Sarepta Therapeutics
Market Cap: US$5.2b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$53.79
7D
5.4%
1Y
-53.5%
Charles River Laboratories International
Market Cap: US$5.2b
Charles River Laboratories International, Inc.
CRL
US$106.05
7D
6.3%
1Y
-53.2%
Nuvalent
Market Cap: US$5.1b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$71.64
7D
8.1%
1Y
14.1%
Axsome Therapeutics
Market Cap: US$5.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$104.46
7D
6.5%
1Y
53.8%
WuXi XDC Cayman
Market Cap: HK$38.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$31.85
7D
-5.3%
1Y
83.5%
Cytokinetics
Market Cap: US$4.7b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$39.48
7D
2.1%
1Y
-41.6%
Zealand Pharma
Market Cap: DKK 30.0b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 424.50
7D
-0.7%
1Y
-27.2%
Ionis Pharmaceuticals
Market Cap: US$4.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$28.40
7D
1.8%
1Y
-30.2%